Lista de obras - Benjamin Durham - Dominio Público Uruguay

A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1

scientific article published on 08 May 2019

A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease.

artículo científico

ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.

artículo científico publicado en 2017

Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells

artículo científico publicado en 2017

An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.

artículo científico publicado en 2018

Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease

artículo científico publicado en 2016

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

artículo científico publicado en 2018

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

artículo científico publicado en 2016

Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

artículo científico publicado en 2015

Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells.

artículo científico publicado en 2015

Efficacy of MEK inhibition in patients with histiocytic neoplasms

scientific article published on 13 March 2019

Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins

artículo científico publicado en 2016

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells

artículo científico publicado en 2017

Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis

artículo científico publicado en 2018

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.

artículo científico publicado en 2017

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

artículo científico publicado en 2017

Histiocytic neoplasms in the era of personalized genomic medicine

artículo científico publicado en 2016

Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas

artículo científico publicado en 2015

Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene

article published in the Proceedings of the National Academy of Sciences of the United States of America

Loss of BAP1 function leads to EZH2-dependent transformation

artículo científico publicado en 2015

MSI2 is required for maintaining activated myelodysplastic syndrome stem cells

artículo científico publicado en 2016

Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition

artículo científico publicado en 2021

Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins

artículo científico publicado en 2016

Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis

scientific article published on 23 April 2019

Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages.

artículo científico publicado en 2018

Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis

artículo científico publicado en 2017

Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice

artículo científico publicado en 2018

Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies

artículo científico publicado en 2018

Rapidly progressive primary leptomeningeal atypical teratoid/rhabdoid tumor: a report of 2 cases

artículo científico publicado en 2012

Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status".

artículo científico publicado en 2016

Resistant Fusarium keratitis progressing to endophthalmitis

artículo científico

Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.

artículo científico publicado en 2017

Single-agent dabrafenib for BRAFV600E-mutated histiocytosis.

artículo científico publicado en 2018

Sonographic appearance of a dermoid cyst (mature cystic teratoma) of the spleen

artículo científico publicado en 2014

Supplementary Figure from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations

article

The clinical spectrum of Erdheim-Chester disease: an observational cohort study

article

The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort.

artículo científico publicado en 2017

miR-99 regulates normal and malignant hematopoietic stem cell self-renewal.

artículo científico publicado en 2017

Lista de obras de Benjamin Durham

A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1

A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease.

ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.

Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells

An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.

Anakinra as efficacious therapy for 2 cases of intracranial Erdheim-Chester disease

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling

Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells.

Efficacy of MEK inhibition in patients with histiocytic neoplasms

Erratum: Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells

Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis

Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.

High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis.

Histiocytic neoplasms in the era of personalized genomic medicine

Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas

Impaired hematopoiesis and leukemia development in mice with a conditional knock-in allele of a mutant splicing factor gene

Loss of BAP1 function leads to EZH2-dependent transformation

MSI2 is required for maintaining activated myelodysplastic syndrome stem cells

Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition

Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins

Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis

Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages.

Novel activating BRAF fusion identifies a recurrent alternative mechanism for ERK activation in pediatric Langerhans cell histiocytosis

Nutritional Support from the Intestinal Microbiota Improves Hematopoietic Reconstitution after Bone Marrow Transplantation in Mice

Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies

Rapidly progressive primary leptomeningeal atypical teratoid/rhabdoid tumor: a report of 2 cases

Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status".

Resistant Fusarium keratitis progressing to endophthalmitis

Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML.

Single-agent dabrafenib for BRAFV600E-mutated histiocytosis.

Sonographic appearance of a dermoid cyst (mature cystic teratoma) of the spleen

Supplementary Figure from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Supplementary Figure from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations

The clinical spectrum of Erdheim-Chester disease: an observational cohort study

The histopathology of Erdheim-Chester disease: a comprehensive review of a molecularly characterized cohort.

miR-99 regulates normal and malignant hematopoietic stem cell self-renewal.